Effects of the anaphylatoxin, C5a, on renal and glomerular hemodynamics in the rat  by Pelayo, Juan C. et al.
Kidney international, Vol. 30 (1986), pp. 62-67
Effects of the anaphylatoxin, C5a, on renal and glomerular
hemodynamics in the rat
JUAN C. PELAYO, DENNIS E. CHENOWETH, TONY E. HUGLI, CURTIS B. WILsoN,
and ROLAND C. BLANTZ
Departments of Medicine and Pathology, University of California, San Diego School of Medicine and Veterans Administration Medical
Center, San Diego, and the Department of immunology, Scripps Clinic and Research Foundation, La Jolla, California, USA
Effects of the anaphylatoxin, C5a, on renal and glomerular hemody-
namics in the rat. The effects of intrarenal infusion of the comple-
ment—derived anaphylatoxin, C5a, upon glomerular hemodynamics
were examined in the Munich—Wistar rat, a strain with glomeruli on the
kidney surface. Human C5a (1.5 sg/min) or vehicle was infused into the
left renal artery for 12 mm, and glomerular capillary (P0) and Bowman's
space pressures, nephron plasma flow (SNPF) afferent and efferent
arteriolar protein concentrations, nephron filtration rate (SNGFR) and
the glomerular ultrafiltration coefficient (LpA) determined. Human C5a
infusion resulted in a reduction in SNPF due to increased efferent
arteriolar resistance, and PG increased which maintained SNGFR
constant. LpA was numerically lower but not significantly decreased.
Infusion of porcine CSade, Arg decreased glomerular filtration rate and
renal blood flow. No polymorphonuclear leukocytes were observed
within glomerular capillaries of C5a infused rats, and rat leukocytes did
not exhibit receptors for human C5a infused. Renal artery infusion of
either human C5a or porcine C5a resulted in renal hemodynamic
alterations and, as documented for human C5a, effects of C5a upon
renal vascular resistance can be added to the known effect of C5a on the
polyrnorphonuclear leukocyte.
nature, Later studies from this laboratory revealed that al-
though histamine and angiotensin 1117] did not contribute to
this observed, complement—dependent vasoconstriction, infu-
sion of the a-adrenergic antagonist, phentolamine, eliminated
the vasoconstriction [7].
Basic studies have suggested that certain complement com-
ponents, notably the anaphylatoxins, C3a, C4a and C5a, may
exert vasoactive properties when topically applied [8—12].
These effects may relate to influences by the polymorphonu-
clear leukocyte and secondary rheologic changes in blood.
However, anaphylatoxins may also exert direct vascular ef-
fects. The current study was designed to examine the renal
hemodynamic effects of the anaphylatoxin, C5a, in the absence
of a complete, immune—induced inflammatory response.
Methods
Experimental animals
Complement activation appears to be a critical component of
the inflammatory response contributing to alterations in glomer-
ular hemodynamics which characterize acute glomerular im-
mune injury [1—4]. We have previously demonstrated that after
systemic administration of large doses of antiglomerular base-
ment membrane antibody (AGBM Ab), the nephron filtration
rate (SNGFR) decreased significantly within 45 to 60 mm due to
both reductions in nephron plasma flow (SNPF) and the glomer-
ular ultrafiltration coefficient (LpA) [4, .5]. The hydrostatic
pressure gradient concomitantly increased, which actually ame-
liorated the reduction in SNGFR. However, when rats were
previously complement depleted with cobra venom factor, the
vasoconstriction was nearly eliminated and the reduction in
LpA was diminished [41. These latter effects of complement
depletion were explained by a decrease in the number of
polymorphonuclear leukocytes within the glomerular capillar-
ies. The near elimination of vasoconstriction by complement
depletion could not be readily explained by any morphologic
findings since the vasoconstriction appeared to be functional in
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The current studies were performed on Munich—Wistar rats
(187 to 300 g body wt), bred and maintained in a colony housed
at the Animal Research facility at the Veterans Administration
Medical Center, San Diego, California.
Preparation of C5a
Human C5a anaphylatoxin was purified to homogeneity from
zymosan—activated serum in the presence of 1mM DL-2-
mercaptomethyl-3-guanidinoethylthiopropanoic acid (Calhio-
chem, La Jolla, California, USA), the carboxypeptidase N
inhibitor, by accepted methods [131. Porcine C5adeg Arg was
purified from zymosan—activated porcine serum in the absence
of the carboxypeptidase N inhibitor [14]. Both preparations
were quantitated by amino acid analysis and homogeneity
assessed by cellulose acetate electrophoresis at pH 8.5.
Surgical preparation and micropuncture protocol
Surgical preparation was nearly identical to that utilized in
previous publications from this laboratory [15]. Tracheostomy
was performed and PE-50 catheters were placed into the left
jugular vein, femoral artery, and bladder. The kidney was
surgically exposed via a left flank incision and the kidney placed
into a lucite cup. The left ureter was cannulated with PE-50
tubing and the left renal artery exposed. A sharpened silicon-
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ized glass pipet (100 jM tip), was then inserted into the left renal
artery and attached to PE-JO tubing via a 28 gauge siliconized
metal connector. Control solutions were isotonic NaC1—
NaHCO3 containing 1 g% human serum albumin. For C5a
studies, C5a was added to this solution to deliver 1.5 g/min of
C5a at an intraarterial infusion rate of 50 d1min for a period of
12 mm (total dose 15 j.tg).
One hr prior to either C5a or control intraarterial infusion, 3H
inulin infusion was begun to deliver approximately 120 SC/hr at
a maintenance rate of 1.5 mI/hr of isotonic NaCI—NaHCO3. At
this time, an infusion was begun to deliver 2.5% body wt
isoncotic plasma and 1.5% body wt isotonic NaC1—NaHCO3
over 60 mm [4, 5]. After equilibration, control intraarterial
infusion was administered to control rats (N = 6) and C5a
solution to the experimental group (N = 6) over a 12 mm
period. In both groups, glomerular capillary (PG), Bowman's
space (PBS), and efferent peritubular capillary (HPE) hydrostatic
pressures were measured utilizing a servo-nulling device with 1
to 2 M tip pipets. At least three blood samples were obtained
from efferent peritubular capillary 'star" vessels for the mea-
surement of protein concentration. At least five timed proximal
tubular samples were obtained for determination of nephron
filtration rate (SNGFR). Kidney GFR and renal plasma flow
(RPF) were measured as previously described 151.
Morphologic studies
Tissue for histologic, and electron microscopic analyses were
obtained at the end of each physiologic study, Methods were as
described in previous publications [4—7]. In a separate group of
rats, histology was evaluated immediately after the 12 mm C5a
intra-renal artery infusion to determine specifically whether
polymorphonuclear leukocytes accumulated within the glomer-
ular capillaries.
Studies with porcine C5ade. Arg
In order to compare effects of C5a derived from another
species, porcine C5ad Arg was infused into the suprarenal aorta
via a PE-lO catheter passed from the left femoral artery to
administer varying quantities of CSades Aig over 0.5 mm (N 4).
The right renal artery was occluded during infusion of either
control solutions or solutions containing CSades Arg' Rats under-
went 2.5% body wt plasma expansion prior to the control
period. The left ureter was catheterized in order to evaluate
whole kidney GFR and plasma flow from the left kidney
[5]. Two five mm urine collections were obtained in each of
three consecutive periods: I) after infusion of 0.5 ml of
carrier solution (1 g% human serum albumin in isotonic
NaCI—NaHCO3) administered over 0.5 mm; 2)1.5 porcine
Ag in 0.5 ml of carrier solution adniinistered over 0.5
mm; and 3) 3.0 sg of porcine C5ad Aug in carrier solution
administered over 0.5 mm.
Studies on the binding of human '251-C'5a to rat leukocytes
These studies were designed to demonstrate that human C5a
does not bind to rat lcukocytes and therefore cannot be leuko-
aggregating or attracting in the rat. Leukocytes were obtained
from Munich—Wistar rats and added to 90 sl RPMI and 1% BSA
solution in quantities varying from I x 106 to 5 x 106 cells. To
this suspension was then added 10 1 of 10 flM human 1251-C5a
in 1% BSA in order to achieve a final human C5a concentration
of 1 n (the approximate K0 for binding of human C5a to
human teukocytes). This mixture was then incubated at room
temperature for 15 mm, the cells separated, and the percent
binding of total radioactivity to the cell fractions determined at
1 to 5 x 106 cells per volume evaluated [161. Using this
procedure, 0.5 x 106 human polymorphonuclear leukocytes
bind 60% of the '251-C5a in the solution. Results are presented
as percent binding of total 1251-C5a to rat leukocytes.
Analytic methods
Protein concentration in systemic and efferent peritubular
capillary plasma samples was measured by a microadaptation of
the Lowry protein method [17, 18]. SNGFR, GFR, kidney renal
plasma flow (RPF) and renal blood flow (RBF), and urine and
plasma and sodium concentrations were determined as de-
scribed in previous studies from this laboratory [4, 5]. Urine
protein excretion from the left kidney was determined by the
sulfosalicylic acid method.
Statistic
Statistical significance was determined by either unpaired
t-test or paired t-test where appropriate as previously described
[4-7].
Calculations
Superficial nephron filtration fraction (SNFF), single nephron
renal plasma flow (SNPF), afferent arteriolar resistance (AR),
efferent arteriolar resistance (ER) and oncotic pressure (jr) from
protein concentration (C) were calculated as described in pre-
vious publications [4—6, 45].
The four factors that determine the SNGFR are the hydro-
static pressure gradient acting across the glomerular membrane
(P), systemic oncotic pressure (IrA), glomerular ultrafiltration
coefficient (LpA), and the single nephron plasma flow rate
(SNPF).
Because P = PG Pus, where PG is the directly measured
glomerular capillary hydrostatic pressure and PBS is the hydro-
static pressure in Bowman's space, the effective filtration
pressure (EFP) can be defined as follows:
EFP = LP —
where r is the oncotic pressure.
As a consequence of glomerular ultrafiltration, ir rises along
the length of the glomerular capillary (x*) as a result of the
increase in protein concentration (C). The mean EFP (EFP) is
defined as follows:
=
'J'0 (P — ir) dx*
Changes in SNPF modify the EFP profile along x* by
affecting the rate at which protein is concentrated and the rate
of rise in ir along x5. The SNOFR can therefore be determined
as follows:
SNGFR = LpA x
where LpA is the glomerular ultrafiltration coefficient and
which in turn is a product of the hydraulic conductivity (Lp) of
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Table 1. Effect of intrarenal infusion of controI vehicIc and the complement anaphylatoxin, C5a, upon glomerular hemodynamics in the rat
AR ER
MAP P0 PBS P TA 7E x/O° X109 EFPA EFP EFP LpA
mm mm mm mm mm SNGFR SNPF SNBF mm mm dyn s dyn s mm mm mm ni/seci
Hg Jig Hg Hg Hg ni/mm ni/mm ni/mm Hg Hg cm5 cm5 Hg Hg Hg mm Hg
Control 113 51 14 37 18 48 225 402 20 29 14 9 18 8 13 0.067
C5a, 1.25 jg/min 117 56 13 43 17 49 182 323 19 32 16 13 24 11 17 0.053
x 12mm ±5 ±1 ±1 ±1 ±1 ±2 ±12 ±20 ±1 ±2 ±2 ±1 ±2 ±3 ±3 ±0.008
Significance, P NS <0.02 NS <0.001 NS NS <0.05 <0.05 NS NS NS <0.005 <0.05 NS NS NS
Subscripts A and E refer to the afferent and efferent effective filtration pressure acting across the glomerular capillary.
the glomerular membrane and A, the total filtering surface area
of the glomerular capillary.
Results
Physiologic effects of porcine C5ades Arg
Measurements were obtained after brief infusions of carrier
solutions containing CSade. Arg There were no changes in either
systemic blood pressure or the appearance of the kidney during
or after porcine CSade,, Arg infusion.
Control GFR was 1.62 ± 0.08 mI/mm, and after the 1.5 pg
bolus of CSades Arg given over 0.5 mm, GFR was 1.45 ± 0.06
mi/mm (NS). However, after 3.0 pg of porcine CSades Arg was
infused, GFR fell to 1.07 ± 0.13 mi/mm (P < 0.01). Renal
plasma flow also decreased only at the higher concentration of
infused porcine C5ade. Arg (control 7.5 ± 0.6 mI/mm, 6.6 ± 0,9
mi/mm after 1.5 pg C5ades Arg (NS) and 5.0 ± 0.3 mI/mm after
3.0 pg C5ades Arg infusion, P < 0.01).
Hemodynamic results with porcine C5ad. Arg clearly demon-
strate a reduction in both GFR and renal plasma flow. How-
ever, whether this effect was totally the result of the influence of
porcine CSades Arg in renal vascular resistance vessels or par-
tially due to accumulation of polymorphonuclear leukocytes
was not entirely clear, since it was likely that porcine CSades Arg
might bind to rat leukocytes as well. We therefore examined the
complete giomerular hemodynamic response to the intrarcnal
infusion of human C5a, since preliminary data had suggested
that rat leukocytes do not possess receptors capable of binding
human C5a.
Renal response to intrarenal ar1et infusion ofhuman C5a
Measurements were obtained in two groups of rats: I) a
control group in which isotonic solution was infused into the left
renal artery over 12 mm (N = 6); and 2) a group in which CSa
was infused in an identical volume over 12 mm (N = 6). The
general appearance of the kidney surface was not altered during
the C5a infusion nor during 40 mm measurement period which
followed.
Urinary protein excretion was not increased by C5a infusion
(2.6 ± 0.5 pg/mm, control vs. 2.1 ± 0.6 pg/mm after C5a
infusion,NS). Urinarysodiumexcretion(l.4 ± 0.3vs. 1. ± 0.2
pEq/min, NS) was not altered by C5a infusion. GFR was not
different in rats infused with C5a (1.29 ± 0.08 mI/mm, control
vs. 1.11 ± 0.07 mI/mm, C5a, NS). Renal plasma flow (4.9 ± 0.5
vs. 4.4 ± 0.6 mI/mm, NS) and renal blood flow (8.8 ± 0.8 vs.
7.9 ± 1.1 mI/mm, NS) were not significantly decreased after
C5a. Mean arterial pressure and SNGFR were not altered by
C5a infusion (Table 1). Single nephron plasma flow (SNPF) and
blood flow (SNBF) were decreased significantly in C5a infused
rats (Table 1). The glomerular capillary hydrostatic pressure
gradient (P) was increased (P < 0.00 1) solely as a result of an
increase in PG, since Bowman's space pressure was unchanged
(Table 1). The increase in P0 was the result of a significant
increase in efferent arteriolar resistance (ER) from 9 ± 1 to
13 ± 1 dynes sec cm5 x iO (P < 0.005). Afferent arteriolar
resistance was numerically higher, but not significant.
The mean effective filtration pressure was numerically, but
not significantly, higher in C5a infused rats. LpA was also
numerically lower, but these values did not achieve signifi-
cance.
Studies on the binding of human '251-C5a to Munich—Wistar
rat ieukocytes
In order to verify that the glomerular hemodynamic effects of
human C5a infusion was the result of a vascular response rather
than the accumulation of leukocytes within glomerular capillar-
ies, binding studies were performed to determine if rat leuko-
cytes possess receptors for human C5a. Normally, 0.5 x 106
human polymorphonuclear leukocytes bind 60% of human
'251-C5a in this assay system [16]. Binding studies were con-
ducted with 1, 2, 3, 4 and 5 x 106 rat leukocytes at 1 nM
1251-C5a. Results expressed as percent cell binding were
—1.6%, —2.6%, —2.6%, —2.0%, and —0.8%atlto5 x 106 rat
leukocytes added, respectively. None of these values were
different from zero binding, demonstrating that leukocytes
derived from the Munich—Wistar rats utilized in this study do
not possess receptors capable of binding human C5a. Attraction
and aggregation of leukocytes in response to human C5a
infusion should not have logically contributed to the glomerular
hemodynamic responses observed.
Morphologic evaluation of human C5a intrarenal infusion
studies
Light microscopic evaluation of kidneys obtained either at
the end of the physiologic measurements or in a separate group
of rats immediately after the C5a infusion revealed no histologic
abnormalities of glomeruli as a result of the C5a infusion.
Specifically, there was no increase in the number of polymor-
phonuclear leukocytes within glomerular capillary lumina by
light microscopic evaluation.
Evaluation of renal tissue by electron microscopy revealed
basically normal glomerular endothelial cells, basement mem-
brane and epithelial cells in control and C5a treated rats. As in
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the light microscopic evaluation, no accumulation of polymor-
phonuclear leukocytes were observed within the glomerular
capillaries and no attachment of these cells to the capillary
membrane was noted. No detachment of the endothelial cell
from the basement was observed.
Discussion
The physiologic consequences of immune injury are a com-
plex product of the actions of several overlapping and interact-
ing mediator systems. It has become increasingly apparent that
activation of the complement cascade is critical to the full
expression of an immune—induced inflammatory response. Ev-
idence has accumulated which suggests that complement com-
ponents contribute to the inflammatory response by several
differing mechanisms [1-4, 8—11]. Both Couser and Salant and
their coworkers have suggested that the terminal complement
components, CSb-C9, constitute a membrane attack complex
capable of inducing injury to the glomerular capillary membrane
in the absence of cells, resulting in glomerular proteinuria [19,
201. The complement anaphylatoxins, C3a and C5a, are capable
of attracting polymorphonuclear leukocytes and contributing to
cell attachment and injury to capillary membranes [8—Il, 211.
Human C5ad Arg has been shown to increase vascular perme-
ability in conjunction with polymorphonuclear leukocytes and
in the presence of the prostaglandin PGE2. We have also
demonstrated that reduction in the glomerular ultrafiltration
coefficient, LpA, which results acutely from infusion of large
doses of antiglomerular basement membrane antibody, can be
greatly ameliorated by prior complement depletion, and that
this beneficial effect correlates with a reduction in the number
of polymorphonuclear leukocytes within the glomerular capil-
laries [4].
More recent studies have suggested effects of C3a and CSa
which are not dependent upon participation of the polymorpho-
nuclear leukocytes. Stimler, Hugh and coworkers have shown
bronchiolar and pulmonary arterial smooth muscle constriction
with CSad Ai anaphylatoxin [9, 11]. Evidence provided sug-
gested that this constriction may be due to secondary activation
or release of Icukotrienes in the lung [11]. Recent evidence from
isolated guinea pig blood vessels suggests that prostaglandins
play a major role in anaphylatoxin—induced vasoconstrictiun
[121. Investigators have shown that C5a will produce contrac-
tion of the ileum, but in this case, contraction can be prevented
by treatment with certain antihistamines. suggesting that CSa
may act through a variety of sccondary biologically active
vasoconstrictor systems [22]. Our own studies have demon-
strated that prior complement depletion prevented renal vaso-
constriction after the administration of AGBM-Ah, and did so
in the absence of any morphologic alterations in the major
resistance arterioles [4]. These studies suggested that the func-
tional vasoconstriction which occurs after AGBM-Ah adminis-
tration was due to some complement component, and based
upon the literature, C3a, C4a or CSa are likely candidates. Later
studies from our laboratory also demonstrated that infusion of
the alpha—adrcnergic antagonist, phentolamine, prevented this
vasoconstriction [7]. However, phentolamine failed to influence
the vasoconstrictor effect of C3a or CSa on isolated guinea pig
vessels [121, suggesting the in vivo action of phentolamine may
be less specific or that adrenergic innervation is required.
Because of suggestions from the literature that complement
anaphylatoxins may exert effects within the vasculature, we
designed the current study to examine the isolated renal effects
of intrarenal C5a. We utilized human C5a in the rat for two
reasons. First, the availability of C5a preparations in the human
made the study practical. Second, human C5a does not interact
with receptors on rat polymorphonuclear leukocytes, as dem-
onstrated in this study in the Munich—Wistar rat and in studies
by others (K. W. Mellison and 0. W. Carter, personal commu-
nications). The latter observation permitted a more accurate
assessment and prediction of the infused C5a levels, since
polymorphonuclear leukocytes did not bind C5a from the
plasma. Other studies have suggested indirectly that CSa recep-
tors on leukocytes and smooth muscle must differ significantly
in that in vitro studies have separated the leukotactic and
constriction effects of C5a [8, 11]. The fact that human CSa does
not interact with receptors on rat polymorphonuclear leuko-
cytes was also verified by the observation that histologic
evaluation revealed no accumulation of polymorphonuclear
leukocytes within renal capillaries after C5a infusion.
Therefore, the renal effects of CSa in this study are likely
separate from those related to accumulation and aggregation of
leukocytes. C5a infusion into the renal artery did produce
significant alterations in glomerular hemodynamics as evaluated
by micropuncture measurements. Nephron plasma flow de-
creased almost entirely as a consequence of increases in ef-
ferent arteriolar resistance. This increase in efferent resistance
with human CSa also produced an increase in P and AP,
thereby helping to maintain SNGFR constant in spite of the
decrease in nephron plasma flow. This constellation of findings
is similar to the findings with acute antiglomerular basement
membrane antibody infusion, a complement fixing antibody [4,
51. The vasoconstriction observed after AGBM-Ab has been
shown to be functional in nature and largely prevented by prior
complement depletion [41. It is quite possible that CSa or the
other anaphylatoxins, C4a and C3a, may participate in this
functional vasoconstriction. An obvious problem encountered
in this study is that we do not know the local concentration of
CSa which can be generated during immune induced glomerular
injury. Such estimates are also complicated by the fact that
intact C5a is rapidly converted in serum to the much less active
form of CSades Arg We used levels that proved to elicit a
response, but much higher local concentrations may be gener-
ated during the immune—induced inflammatory event. Since
porcine C5ad. A also decreased renal plasma flow, this effect
is not peculiar to human CSa. We also do not know whether
these vascular events are a direct consequence of CSa activity
in renal vessels or whether C5a acts via another vasoconstrictor
system (that is, leukotrienes or adrenergic stimulation). The
design of the current experimental protocol was to infuse CSa
and then conduct physiologic measurements within approxi-
mately 40 mm after termination of Cia infusion. It is likely that
these physiologic effects are not the consequence of a direct and
persisting Cia influence, but a result of the action of secondary
mediators initiated by infusion of CSa. Recent studies by
Schreiner and Moore have shown decreases in angiotensin II
receptors in the glomerular mcsangial cell after immune expo-
sure, an event that may be induced by the participation of
complement products [23]. The mechanism whereby comple-
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ment components may interact with this intrarenal vasocon-
strictor system is currently unknown,
CSades Arg is normally considered less potent than intact C5a
as both a spasmogen within the vasculature and a Ieukoattract-
ant. We observed vasoconstriction in this study in the rat in
response to both human C5a and lesser absolute quantities of
porcine CSades Arg, which might be considered a surprising
result. There are at least three potential explanations for these
findings. The studies with porcine CSade. Arg were performed
initially in sequence, due to availability of this material, and the
design differed in that boluses were administered over 0.5 mm.
It is possible that with this approach, higher plasma levels of
porcine CSade. Arg may have been achieved for short periods.
Although conversion of human C5a to CSade. Arg diminishes
potency as a vasoconstrictor by three to four orders of magni-
tude, conversion of porcine C5a to CSade. Arg results in a
relatively well maintained vasoconstrictor effect [81. Some of
the human C5a infused was undoubtedly also converted to the
much less active human C5ad. Arg in plasma. Finally, studies
were conducted with human C5a, in part, because it was
impossible to exclude an effect of porcine CSades Arg upon rat
leukocytes, because of the more similar structure of C5a in rat
and pig. Therefore, it remains possible that some of the renal
vascular effects of porcine CSades Aig, but not human C5a, might
have resulted from attraction of rat leukocytes.
The LpA did not decrease after C5a infusion, although there
was a small numerical trend for a reduction. This finding does
not prove that C5a does not contribute to the partially comple-
ment dependent decrease in LpA after immune injury induced
by AGBM-Ab. These complement dependent events in the
complete inflammatory response are likely mediated by attrac-
tion of polymorphonuclear leukocytes. Human C5a should not
have attracted polymorphonuclear leukocytes into glomerular
capillaries of the rat, as demonstrated by histologic evaluation
and the absence of receptors on rat leukocytes. In spite of
absence of receptors for human C5a on rat leukocytes and the
lack of a demonstrable increase in polymorphonuclear leuko-
cytes in glomerular capillaries by light and electron microscopy,
there is no way to absolutely exclude some role for the
polymorphonuclear leukocyte in the renal hemodynamic alter-
ations observed. However, spontaneous local complement ac-
tivation in the rat does cause leukocyte infiltration into capil-
laries, and normal rat C5a is the likely chemotactic factor.
Renal vascular effects of C5a would merely add to the docu-
mented effects of the anaphylatoxin on the polymorphonuclear
leukocyte.
The current study demonstrates that anaphylatoxins exert
effects within the renal vasculature, and appear to do so
independent of C5a effects on the polymorphonuclear leuko-
cyte. These findings are similar to those which have been
indirectly observed in other organs [8, 111. Anaphylatoxins may
participate importantly in acute alterations in glomerular hemo-
dynamics through effects on leukocytes and direct effects on
renal vasculature.
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